Skip to main content
Top
Published in: Tumor Biology 12/2014

Open Access 01-12-2014 | Research Article

Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish population

Authors: Izabela Laczmanska, Lukasz Laczmanski, Marek Bebenek, Pawel Karpinski, Halina Czemarmazowicz, David Ramsey, Andrzej Milewicz, Maria M. Sasiadek

Published in: Tumor Biology | Issue 12/2014

Login to get access

Abstract

The protective effect of vitamin D against several cancers including colorectal cancer is modulated by the vitamin D receptor (VDR) and its ligand, the active form of vitamin D. VDR response has been found to play a role in various genes encoding proteins involved in crucial cellular pathways. Single nucleotide polymorphisms (SNPs) of the VDR gene that modulate its activity are located in the promoter region, exons 2–9, and their vicinity and also in the 3′UTR region. Some of them have been previously studied in relation to cancer susceptibility and prognosis. The aim of our study was to investigate four polymorphisms, BsmI, ApaI, TaqI, and FokI, of the VDR gene in Polish patients with sporadic colorectal cancer and to evaluate their association with susceptibility to cancer. We found a significant association between the BsmI genotype and cancer (individuals with the bb genotype are more susceptible to cancer compared to those with other genotypes, p = 0.025, Fisher’s exact test for 2 × 2 table). Also, the TT genotype at TaqI and the AA genotype at ApaI are correlated with a higher risk of cancer (p = 0.00071 and p = 1.0 × 10−5, respectively). We found relatively strong linkage disequilibrium between the TaqI and ApaI loci (T with A and t with a, respectively). Both of these loci are associated with cancer. We do not observe any such association for the FokI polymorphism. In conclusion, a small modification in VDR expression may play a role in such a multipathway process as tumorigenesis.
Literature
1.
go back to reference Perna L, Hoffmeister M, Schöttker B, Arndt V, Haug U, Holleczek B, et al. Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. Cancer Epidemiol. 2013;37:905–7.CrossRef Perna L, Hoffmeister M, Schöttker B, Arndt V, Haug U, Holleczek B, et al. Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. Cancer Epidemiol. 2013;37:905–7.CrossRef
2.
go back to reference Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511–36.PubMed Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511–36.PubMed
3.
go back to reference Di Rosa M, Malaguarnera M, Zanghì A, Passaniti A, Malaguarnera L. Vitamin D3 insufficiency and colorectal cancer. Crit Rev Oncol Hematol. 2013;88:594–612.CrossRef Di Rosa M, Malaguarnera M, Zanghì A, Passaniti A, Malaguarnera L. Vitamin D3 insufficiency and colorectal cancer. Crit Rev Oncol Hematol. 2013;88:594–612.CrossRef
4.
go back to reference Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003–16.CrossRef Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003–16.CrossRef
5.
go back to reference Uitterlinden A, Fang Y, Van Meurs J, Pols H, Van Leeuwen J. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143–56.CrossRef Uitterlinden A, Fang Y, Van Meurs J, Pols H, Van Leeuwen J. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143–56.CrossRef
6.
go back to reference Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284–7.CrossRef Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284–7.CrossRef
7.
go back to reference Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab. 1995;80:2800–5.PubMed Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, et al. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab. 1995;80:2800–5.PubMed
8.
go back to reference Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012;18:1672–9.CrossRef Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012;18:1672–9.CrossRef
9.
go back to reference Karpinski P, Szmida E, Misiak B, Ramsey D, Leszczynski P, Bebenek M, et al. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis. Mol Carcinog. 2012;51:1003–8.CrossRef Karpinski P, Szmida E, Misiak B, Ramsey D, Leszczynski P, Bebenek M, et al. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis. Mol Carcinog. 2012;51:1003–8.CrossRef
10.
go back to reference Laczmanska I, Pesz K, Laczmanski L. Application of selected methods based on the polymerase chain reaction in medical molecular diagnostics. Adv Clin Exp Med. 2009;18:85–92. Laczmanska I, Pesz K, Laczmanski L. Application of selected methods based on the polymerase chain reaction in medical molecular diagnostics. Adv Clin Exp Med. 2009;18:85–92.
11.
go back to reference Lins TCL, Nogueira LR, Lima RM, Gentil P, Oliveira RJ, Pereira RW. A multiplex single-base extension protocol for genotyping Cdx2, FokI, BsmI, ApaI, and TaqI polymorphisms of the vitamin D receptor gene. Genet Mol Res. 2007;6:316–24. Lins TCL, Nogueira LR, Lima RM, Gentil P, Oliveira RJ, Pereira RW. A multiplex single-base extension protocol for genotyping Cdx2, FokI, BsmI, ApaI, and TaqI polymorphisms of the vitamin D receptor gene. Genet Mol Res. 2007;6:316–24.
12.
go back to reference Laczmanski L, Milewicz A, Puzianowska-Kuznicka M, Lwow F, Kolackov K, Mieszczanowicz U, et al. Interrelation between genotypes of the vitamin D receptor gene and serum sex hormone concentrations in the Polish elderly population: the PolSenior study. Exp Gerontol. 2014. doi:10.1016/j.exger.2014.06.007.2014. Laczmanski L, Milewicz A, Puzianowska-Kuznicka M, Lwow F, Kolackov K, Mieszczanowicz U, et al. Interrelation between genotypes of the vitamin D receptor gene and serum sex hormone concentrations in the Polish elderly population: the PolSenior study. Exp Gerontol. 2014. doi:10.​1016/​j.​exger.​2014.​06.​007.​2014.
13.
go back to reference Yasuda N, Tsuji K. A counting method of maximum likelihood for estimating haplotype frequency in the HL-A system. Jinrui Idengaku Zasshi. 1975;20:1–15.PubMed Yasuda N, Tsuji K. A counting method of maximum likelihood for estimating haplotype frequency in the HL-A system. Jinrui Idengaku Zasshi. 1975;20:1–15.PubMed
14.
go back to reference Kass GV. An exploratory technique for investigating large quantities of categorical data. Appl Stat. 1980;29:119–27.CrossRef Kass GV. An exploratory technique for investigating large quantities of categorical data. Appl Stat. 1980;29:119–27.CrossRef
15.
go back to reference Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2752–5.CrossRef Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2752–5.CrossRef
16.
go back to reference Slattery ML. Vitamin D, receptor gene (VDR) associations with cancer. Nutr Rev. 2007;65:S102–4.CrossRef Slattery ML. Vitamin D, receptor gene (VDR) associations with cancer. Nutr Rev. 2007;65:S102–4.CrossRef
17.
go back to reference Parisi E, Reñé JM, Cardús A, Valcheva P, Piñol-Felis C, Valdivielso JM, et al. Vitamin D receptor levels in colorectal cancer. Possible role of BsmI polymorphism. J Steroid Biochem Mol Biol. 2008;111:87–90.CrossRef Parisi E, Reñé JM, Cardús A, Valcheva P, Piñol-Felis C, Valdivielso JM, et al. Vitamin D receptor levels in colorectal cancer. Possible role of BsmI polymorphism. J Steroid Biochem Mol Biol. 2008;111:87–90.CrossRef
18.
go back to reference Fedirko V, Riboli E, Tjønneland A, Ferrari P, Olsen A, Bueno-de-Mesquita HB, et al. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev. 2012;21:582–93.CrossRef Fedirko V, Riboli E, Tjønneland A, Ferrari P, Olsen A, Bueno-de-Mesquita HB, et al. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev. 2012;21:582–93.CrossRef
Metadata
Title
Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish population
Authors
Izabela Laczmanska
Lukasz Laczmanski
Marek Bebenek
Pawel Karpinski
Halina Czemarmazowicz
David Ramsey
Andrzej Milewicz
Maria M. Sasiadek
Publication date
01-12-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2554-0

Other articles of this Issue 12/2014

Tumor Biology 12/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine